Evaluation of Novel Trend Arrow Adjustment Tool for Diabetes Patients Using Continuous Glucose Monitoring to Guide Insulin Bolus Adjustment (TAAT Study)
NCT02064647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2016-01-28
Summary
Continuous glucose monitoring (CGM) provides up to 288 blood glucose levels per day, updated every 5 minutes and displayed in real-time on the insulin pump, which can be used to enhance delivery of insulin through pump therapy. In addition this real-time CGM data includes "trend arrows" which indicate when the blood glucose is rapidly falling or rising thus enabling the pump user to make immediate adjustments in insulin delivery to prevent subsequent low or high blood sugars. The trend arrows are displayed when the blood glucose is rapidly falling or rising. For example, if the glucose is increasing by 1-2 mmol/L over 20 minutes, a single upward arrow alerts the pump wearer, who can then decide to give a bolus of insulin or increase the meal bolus. Should the glucose level be increasing at a rate greater than 2mmol/L over 20 minutes, 2 upward arrows are displayed and the user could decide to give a larger bolus. The purpose of the bolus adjustment is to add insulin for the predicted rise in glucose to prevent or reduce subsequent hyperglycemia. Similarly, a decrease in the insulin bolus is advised if glucose levels are falling as evidenced by one or two downward arrows.
However, effective strategies for adjusting insulin boluses based on CGM trend arrows are lacking. The JDRF CGM Study Group recommended that boluses be adjusted based on trend arrows using a standard 10-20% increase/decrease of the total original recommended bolus dose (10% for one arrow up or down, and 20% for two arrows up or down), with the original bolus dose calculated by the pump calculator (i.e. Bolus Wizard). However, the original recommended bolus dose is dependent on the amount of food to be consumed (grams of carbohydrate) and the current blood glucose (if above or below target range), as well as the amount of active insulin, and therefore increasing or decreasing the total recommended bolus by 10-20% may overcompensate for the trend arrows and result in postprandial hypoglycemia. Attempts to use the10/20% formula within CHEO's large pediatric pump/CGM population resulted in low acceptance and adherence by CGM users.
The CGM TIME Trial Study Group develop an innovative tool for adjusting boluses for CGM trend arrows based on the patient's own insulin sensitivity factor (ISF). The Trend Arrow Adjustment Tool formula is: if CGM shows a single arrow up or down: adjust bolus by +/- (1.5/ISF) and for 2 arrows up or down +/- (3/ISF). Use of the Trend Arrow Adjustment Tool within the CGM TIME Trial appears to lead to more appropriate adjustment in bolus dosing, and more effective prevention of subsequent hyper- and hypoglycemia. Furthermore, this tool appears to have excellent uptake amongst the TIME Trial participants, with observations that there is continued usage of the tool throughout the 12 month study, and greater satisfaction with this component of CGM. However, the tool has not been systematically evaluated.
The proposed study will evaluate the Trend Arrow Adjustment Tool, to determine its effectiveness in reducing postprandial hyper- and hypoglycemia, as well as parent, child/youth satisfaction, and ease of use of the tool based on self-report measures. Comparison will be made with the 10/20% bolus adjustment \& also to no adjustments to meal boluses (i.e. ignoring CGM trend arrows). Should use of the Trend Arrow Adjustment Tool lead to more time spent within the target glucose range, this will have immediate clinical benefit for patients, including improved quality of life, and potentially a reduction in HbA1c and prevention of long-term complications.
Conditions
- Diabetes Mellitus, Type 1
Interventions
- OTHER
-
Trend Arrow Adjustment Tool
The Trend Arrow Adjustment Tool formula is: if CGM shows a single arrow up or down: adjust bolus by +/- (1.5/ISF) and for 2 arrows up or down +/- (3/ISF). Where ISF is the patients own insulin sensitivity factor.
- OTHER
-
10/20% bolus adjustment
The 10/20% bolus adjustment formula is: if CGM shows a single arrow up or down: adjust bolus by +/- 10% and for 2 arrows up or down +/- 20%.
Sponsors & Collaborators
-
Juvenile Diabetes Research Foundation
collaborator OTHER -
Children's Hospital of Eastern Ontario
lead OTHER
Principal Investigators
-
Margaret Lawson, MD, MSc, MHSc, FRCP · Children's Hospital of Eastern Ontario Research Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 5 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-05-31
Countries
- Canada
Study Locations
More Related Trials
-
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
NCT01823341 ·Status: COMPLETED ·Phase: PHASE2
-
Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus
NCT01016457 ·Status: UNKNOWN ·Phase: PHASE4
-
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
NCT04668612 ·Status: UNKNOWN ·Phase: NA
-
Adjusting Insulin Delivery to Activity
NCT02299479 ·Status: COMPLETED ·Phase: NA
-
Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients
NCT01525784 ·Status: UNKNOWN
-
Closing the Loop in Youth With Type 1 Diabetes in the Home Setting
NCT01221467 ·Status: COMPLETED ·Phase: PHASE2
-
Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics
NCT05969106 ·Status: COMPLETED
-
Information, Follow-up and Early Diagnosis of Children at Risk for Type 1 Diabetes
NCT06676566 ·Status: ENROLLING_BY_INVITATION
-
Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
NCT01840358 ·Status: UNKNOWN ·Phase: NA
-
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
NCT02129868 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring and Metabolic Control in Children With Type 1 Diabetes
NCT02137031 ·Status: COMPLETED ·Phase: NA
-
Real-time Adaptation to Changes in Insulin Sensitivity
NCT01261052 ·Status: COMPLETED ·Phase: PHASE2
-
Starter Kit Study in Insulin naïve Patients
NCT03365180 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM
NCT00476788 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.
NCT06310980 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Closing the Loop 24/7 in Adolescents With Type 1 Diabetes
NCT01873066 ·Status: COMPLETED ·Phase: NA
-
Assessing the Impact of Control-IQ Technology
NCT04838561 ·Status: COMPLETED
-
Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM
NCT04428762 ·Status: WITHDRAWN ·Phase: NA
-
Effect of CSII and CGM on Progression of Late Diabetic Complications
NCT01454700 ·Status: COMPLETED ·Phase: PHASE4
-
Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes
NCT04878120 ·Status: COMPLETED ·Phase: NA
-
Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1
NCT05610722 ·Status: TERMINATED ·Phase: NA
-
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)
NCT03263494 ·Status: COMPLETED ·Phase: PHASE3
-
Timing of Pre-meal Insulin Versus Accurate Carbohydrate Counting in Youth With Type 1 Diabetes
NCT01209312 ·Status: COMPLETED ·Phase: NA
-
Day and Night Closed-loop in Young People With Type 1 Diabetes
NCT02925299 ·Status: COMPLETED ·Phase: NA
-
Threshold Suspend in Pediatrics at Home
NCT02120794 ·Status: COMPLETED ·Phase: NA